论文部分内容阅读
Atherosclerotic disease, as a systemic process, affectsall arteries to varying degrees. In particular,coexistent carotid and coronary artery diseases arecommon; Management of such patients has been a pointof continuing controversy. Current American HeartAssociation (AHA) guidelines recommend carotidendarterectomy (CEA) in symptomatic patients withcarotid artery stenosis of 50%-99% and in asymptomaticpatients with stenosis of 60%-99%. Carotid arterystenting (CAS) has become a reasonable alternative toCEA, particularly in patients at high risk for CEA. Wesought to assess feasibility, safety and midterm outcomeof carotid artery stenting in patients with coexistingsymptomatic coronary disease and carotid artery stenosis.
In particular, coexistent carotid and coronary artery diseases arecommon; Management of such patients has been a point of continuing controversy. Current American Heart Association (AHA) guidelines recommend carotidendarterectomy (CEA) in symptomatic patients with carotid artery stenosis of 50% -99% and in asymptomatic patients with stenosis of 60% -99%. Carotid arterystenting (CAS) has become a reasonable alternative to CEA, particularly in patients at high risk for CEA. Wesought to assess feasibility, safety and midterm outcomeof carotid artery stenting in patients with coexistingsymptomatic coronary disease and carotid artery stenosis.